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DNA N6-methyladenine (6mA) modification is com-
monly found in microbial genomes and plays impor-
tant functions in regulating numerous biological
processes in bacteria. However, whether 6mA
occurs and what its potential roles are in higher-
eukaryote cells remain unknown. Here, we show
that 6mA is present in Drosophila genome and that
the 6mA modification is dynamic and is regulated
by the Drosophila Tet homolog, DNA 6mA demethy-
lase (DMAD), during embryogenesis. Importantly,
our biochemical assays demonstrate that DMAD
directly catalyzes 6mAdemethylation in vitro. Further
genetic and sequencing analyses reveal that DMAD
is essential for development and that DMAD removes
6mA primarily from transposon regions, which corre-
lates with transposon suppression in Drosophila
ovary. Collectively, we uncover a DNA modification
in Drosophila and describe a potential role of the
DMAD-6mA regulatory axis in controlling develop-
ment in higher eukaryotes.
INTRODUCTION
DNA methylation, an epigenetic mechanism, does not change
DNA sequence but instead suppresses the transcription fac-
tor-DNA association, thereby regulating gene expression and a
variety of cellular processes (Feng et al., 2010; Smith and Meiss-
ner, 2013). Several methylated bases, including 5-methylcyto-
sine (5mC), N6-methyladenine (6mA), and N4-methylcytosine
(4mC), have been found in genomic DNA from diverse species
(Cheng, 1995; Ratel et al., 2006; Wion and Casadesu´s, 2006).
These methylated bases have been shown to be products of
post-replicative DNA modification generated by specific DNA
methylases (Wion and Casadesu´s, 2006). The prevailing view
is that, unlike 5mC, 6mA and 4mC function only in bacteria,
protists, and other lower eukaryotes (Cheng, 1995; Wion and
Casadesu´s, 2006). Among these DNA modifications, 6mA plays
an important role in controlling a number of biological functionsin bacteria, such as DNA replication and repair, gene expression,
and host-pathogen interactions (Reisenauer et al., 1999; Wion
and Casadesu´s, 2006), and is essential for viability of some bac-
terial strains (Julio et al., 2001; Stephens et al., 1996; Wright
et al., 1997). In contrast, 5mC is thought to be the predominant
type, if not the only type, of methylated base in mammals (Smith
and Meissner, 2013).
Recent studies have suggested that methylation/demethyla-
tion at the C-5 position of cytosine in mammals is a dynamic
and reversible process controlled by several mechanisms,
including passive and active demethylation (Bhutani et al.,
2011; Wu and Zhang, 2014). While passive demethylation
is attributed to successive cell divisions that cause a progressive
loss of 5mC on a genome scale, active demethylation is
achieved by ten-eleven translocation (Tet)-mediated oxidation
to 5-hydroxymethylcytosine (5hmC) (Kriaucionis and Heintz,
2009; Tahiliani et al., 2009). It has been shown that 5mC can
be oxidized by the Tet enzymes in an iterative manner to
5hmC, 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC),
and both 5fC and 5caC can be further replaced to unmodified
cytosine by excision repair pathway (He et al., 2011; Ito et al.,
2011; Maiti and Drohat, 2011).
Given the important roles of 6mA modification in bacteria,
we explore whether 6mA plays a role in eukaryotes. However,
previous studies have suggested that the 6mA base is present
at extremely low levels in genomic DNA of higher eukaryotes
(Ratel et al., 2006). We speculate that, if 6mA plays a role, the
potential installation of this modification by methyltransferases
could be reversed by a demethylase-mediated demethylation
process. Since extremely low levels of 6mA are present in
higher eukaryotes, we reason that 6mA demethylases might
play predominant roles in controlling the dynamics of 6mA
DNA modification in higher eukaryotes. Thus, knockout of yet-
to-be identified demethylases could lead to accumulation
of 6mA and allow its functional investigations. In this study, we
identify the Drosophila Tet homolog as the DNA demethylase
that is responsible for 6mA demethylation in Drosophila, and
we name it DNA 6mA demethylase (DMAD).
In Drosophila, 5mC modification exists at an extremely low
level (Lyko and Maleszka, 2011), and the Drosophila Dnmt2-
dependent methylome lacks defined DNA 5mC patterns (Rad-
datz et al., 2013). Thus, whether the Drosophila genome has aCell 161, 893–906, May 7, 2015 ª2015 Elsevier Inc. 893
functional DNA modification remains elusive. In this study, we
show that DNA modification 6mA is present in the Drosophila
genome at a considerable level and that the demethylation of
6mA is tightly regulated by DMAD during embryogenesis and
tissue homeostasis. We also demonstrate that DMAD is likely a
6mA demethylase since it directly catalyzes 6mA demethylation
in vitro. Further genetic and sequencing analyses reveal that
DMAD determines 6mA distribution in the Drosophila genome
and is essential for development.
RESULTS
Characterization of 6mA Modification in Drosophila
Genomic DNA
Previous studies suggested that 5mCmodification in Drosophila
DNA occurs at very low levels, and the Drosophila Dnmt2-
dependent methylome lacks defined DNA 5mC methylation
patterns (Lyko et al., 2000; Raddatz et al., 2013). To further
explore this issue, we employed ultra-high-performance liquid
chromatography-triple quadrupole mass spectrometry, coupled
with multiple-reaction monitoring (UHPLC-MRM-MS/MS) anal-
ysis, an extremely sensitive assay for detecting base modifica-
tion (Yin et al., 2013), to measure the abundance of oxidized
5mC derivatives, 5hmC, 5fC, and 5caC in multiple tissues. The
UHPLC-MRM-MS/MS assays showed that, although 5hmC
was detected in Drosophila DNA at extremely low levels and
fewer than 100 of the cytosine bases per genome were modified
to be 5hmC (Figures S1A–S1C), 5fC and 5caC were not detect-
able in Drosophila DNA. These observations prompted us to
explore whether DNA methylation could occur at other bases.
We turned our attention to explore the possible existence of
adenine methylation in Drosophila DNA.
We used an antibody that is specifically against the 6mA base
in DNA (Figure S1D) and performed dot blot experiments to
detect the 6mA signal in Drosophila DNA samples isolated
from various adult tissues and from embryos at various stages.
As shown in Figure 1A, while relatively weak signals of 6mA
were detected in DNA from adult tissues and late-stage
embryos, a very strong 6mA signal was found to be present in
embryos at the very early stage, suggesting the existence of
6mA in Drosophila DNA and that the status of 6mA modification
might be dynamic during embryogenesis.
We next sought to quantify 6mA in Drosophila DNA using the
UHPLC-MRM-MS/MS method (Figure S1E) and first focused
on measuring the 6mA abundance in DNA at the embryonic
stages. As shown in Figures 1B and 1C, abundance of the
6mA base appeared to display a peak (0.07%, 6mA/dA) at
the 0.75 hr stage but was dramatically reduced to a very low
level (0.001%, 6mA/dA) at the 4–16 hr stages, confirming that
6mA is dynamic in Drosophila DNA during embryonic develop-
ment. Additionally, we also quantified the abundance of 6mA in
adult tissues (e.g., brain and ovary) and found that it exhibited
similar low levels to those found in the late-stage embryonic
genome (Figures 1D and 1E). To confirm that the signal indeed
reveals 6mA modification in Drosophila, we collected the peak
fraction containing 6mA (Figure S1F) and performed a further
high-resolution mass spectrometry analysis. As shown in Fig-
ures 1F–1H, we observed an accurate mass/charge ratio of894 Cell 161, 893–906, May 7, 2015 ª2015 Elsevier Inc.266.1250 au (M+H), which matched the theoretic monoisotopic
mass of 6mA (266.1248 au) with a deviation of 1.02 ppm.
Notably, the isolated compound displayed the same fragment
pattern (20 fragments) as the standard 6mA. Collectively, our
findings support that 6mA is present in fly DNA and is highly
dynamic during early embryogenesis.
Drosophila Embryos Possess DNA 6mA Demethylation
Activity
The observation of a dramatic reduction in 6mA levels in the
Drosophila genome from the very early to the late stages of em-
bryonic development prompted us to ask the intriguing question
of whether active 6mA demethylation occurs during Drosophila
embryogenesis. To explore this issue, we established an
in vitro DNA 6mA demethylation assay. In this assay, we em-
ployed the AlkB, a known 6mA demethylase from bacteria
(Li et al., 2012), as a positive control enzyme (Figure 2A). As
shown in Figure 2B, contrary to the control reaction with adding
the GFP protein, the methylated DNA substrates were signifi-
cantly oxidized in the presence of AlkB in a dose-dependent
manner. We then used this established system to determine
whether the embryonic nuclear extracts have enzymatic activity
for 6mA demethylation. As shown in Figure 2C, addition of seri-
ally diluted nuclear extracts in the enzymatic reaction catalyzed
6mA demethylation in a dose-dependent manner. By contrast,
no or a low background signal of 6mA demethylation was
measured in the control reactions in which GFP was added. Of
note, we found that no or only a low level of background deme-
thylation signal was detected when we added the same number
of boiled nuclear extracts in a parallel control reaction (data not
shown), suggesting that a potential small amount of DNA from
nuclear extracts did not interfere with the signal that we collected
from in vitro reactions.
Interestingly, we detected an increase in 6mA demethylation
activity from nuclear extracts during embryonic development.
As shown in enzymatic assays, the 6mA demethylation activity
of nuclear extracts was relative low at the very early stage but
gradually increased and reached a peak at the 6 hr stage
(Figure 2D). This result demonstrated that 6mA demethylation
activity and abundance of 6mA in embryonic DNA are mutually
complementary with each other during embryonic development
(see Figures 1A, 1C, and 2D). Thus, our findings not only support
that DNA 6mA modification is a dynamic process during
early Drosophila embryonic development, but also raise a possi-
bility that 6mA demethylation is regulated by a specific DNA
dioxygenase.
DMAD Is Involved inRegulatingDNA6mADemethylation
We next aimed to search for the specific enzyme responsible
for 6mA demethylation. Previous studies have shown that
Tet proteins in mammals play important roles in DNA demethyla-
tion through converting 5mC to 5hmC (Kriaucionis and Heintz,
2009; Tahiliani et al., 2009). The Drosophila genome contains a
gene, CG2083, which encodes a putative dioxygenase protein.
Sequence alignment and domain structure analysis suggested
that this protein contains highly conserved domains, including
a CXXC zinc finger (645 aa–684 aa), a Cys-rich domain
(1695 aa–1867 aa), and a DSBH domain (1888 aa–2918 aa),
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Figure 1. Characterization and Quantification of 6mA in Drosophila DNA
(A) Genomic DNAs from embryos at various stages and adult tissues as indicated were subjected to dot blot assays using a specific anti-6mA antibody (left).
Methylene blue hydrate staining was performed to determine the signal of input DNA (right).
(B–E) UHPLC-MRM-MS/MS chromatograms (B and D) and quantification (C and E) of 6mA in genomic DNA of embryos (B and C) and adult tissues (D and E).
(F–H) Control compound and the isolated 6mA compound from fly genomic DNA from 0.5–1.5 hr embryos were subjected to further high-resolution mass-
spectrometry analysis. The collision energy was set at 0 eV (F), 10 eV (G), and 55 eV (H).
The experiments were carried out by triplicates, and the standard deviations were calculated by Excel. See also Figure S1.which are also present in mammalian Tet proteins (Figure 2E). It
is worthwhile to note that the bacterial AlkB protein also contains
a DSBH domain (Figure 2E). Based on the biochemical function
of the CG2083-encoding protein that we characterized below,we thereafter called it Drosophila DNA 6mA demethylase and
abbreviated it as DMAD. Given that DMAD looks more like
mammalian Tet proteins, we first performed an in vitro enzymatic
assay and found that the catalytic domain of DMAD (DMAD-CD),Cell 161, 893–906, May 7, 2015 ª2015 Elsevier Inc. 895
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Figure 2. Demethylation of DNA 6mA Modification by Drosophila Embryo Nuclear Extracts
(A) Schematic representation of in vitro 6mA demethylation. AlkB- and mock-treated nuclear extracts were used in the enzymatic reaction to catalyze the
demethylation of the 6mA in methylated CT DNA, and the products were then subjected to mass spectrometry.
(B) E. coli AlkB, but not mock protein (GFP), catalyzes the demethylation of the 6mA in a dose-dependent fashion.
(C) Nuclear extracts from 6 hr embryos (from 0.5, 1, 2, 5, 10mg embryos as indicated) were tested in the demethylation reaction. In this experiment, AlkB and GFP
were used as positive or negative controls, respectively.
(D) Nuclear extracts (from 2 mg embryos) from various embryonic stages possess enzyme activity for 6mA demethylation.
(E) Schematic diagram showing that DMAD contains three conserved domains—the CXXC zinc finger, the Cys-rich domain, and the DSBH domain—that are also
present in mammalian Tet proteins. The bacterium AlkB contains DSBH, which possesses enzyme activity for 6mA demethylation.
(legend continued on next page)
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but not DMAD-CDmut, could convert 5mC to 5hmC in vitro (Fig-
ures S2A–S2D). However, the in vitro activity of DMAD-CD that
mediates oxidation of 5mC was about 30-fold lower than that
of mouse Tet1-CD (data not shown). Nevertheless, only a few
cytosine bases (less than 100) as mentioned above could be
detected as the hydroxymethylated form, 5hmC, per genome
(Figures S1B and S1C). We speculated that DMAD might play
a role in catalyzing other forms of DNA modification in fly, for
example, 6mA.
We found that the DMAD is weakly expressed during early
embryonic stages but is highly expressed during the later embry-
onic stages (Figures 2F and 2G). Thus, the DMAD expression has
a complementary expression pattern as 6mA during embryogen-
esis. Because nuclear extracts from the late-stage embryos
exhibited considerable 6mA demethylation activity and high
levels of DMAD expression, we asked whether DMAD is involved
in regulating the 6mA demethylation. To do this, we used a spe-
cific anti-DMAD antibody and then performed antibody-deple-
tion experiments. Nuclear extracts with depleted DMAD were
then used in in vitro 6mA DNA demethylation assays. As shown
in Figure 2H, depletion by the anti-DMAD antibody, but not IgG,
significantly blocked the demethylation activity of the nuclear
extracts from the late-stage embryos, arguing that the DMAD
is involved in regulating 6mA demethylation.
To obtain further evidence to support our argument, we next
employed the double-strand RNA (dsRNA) knockdown method
and further evaluated the specificity of DMAD’s role in regulating
6mA demethylation. As shown in Figure 2I, injection of dsRNA
against the DMAD mRNA in embryos significantly reduced the
DMAD expression. As shown in Figure 2J, nuclear extracts
from embryos treated with DMAD dsRNA exhibited much less
6mA demethylation activity than extracts from control embryos,
further confirming the important role of DMAD in demethylating
6mA. In line with this, we observed that knockdown of DMAD
increased the levels of 6mA in late-stage (15 hr) embryos
(Figure S2E). In addition, we found that injection ofDMAD dsRNA
at different developmental time points caused significant
lethality at the late embryonic stage when compared with control
dsRNA injection (Figure S2F), suggesting that DMAD possibly
contributes to embryonic development.
DMAD Is Required for Drosophila Development
To investigate the biological role of DMAD and its relevance to
fly DNA 6mA demethylation in vivo, we sought to generate the
DMAD mutant flies by employing the CRISPR/Cas system.
According to the method described previously (Cong et al.,
2013; Mali et al., 2013), we designed two sgRNAs containing
non-overlapping sequences targeting the DMAD gene and
generated two alleles, DMAD1 and DMAD2, with an independent
genetic background (Figure 3A and Extended Experimental Pro-
cedures). As shown in a western blot assay, DMAD expression(F) Expression levels of DMAD at different embryonic stages as measured by qR
(G) Expression levels of DMAD protein at different embryonic stages measured b
(H) Nuclear extracts treated with anti-DMAD or IgG or without treatment were us
(I) Relative expression levels of DMAD in embryos treated with dsRNA against D
(J) Nuclear extracts from embryos treated with dsRNA against DMAD or gfp wer
The experiments were carried out by triplicates, and the standard deviations wewas completely abolished in the DMAD1 and DMAD2 mutant
allelic combination (Figure 3B), revealing that these two DMAD
mutants are null alleles. To determine the biological role of
DMAD, we performed a genetic complementation test and found
that, while most of trans-heterozygous mutant animals were
lethal at the pupa stage, a small population of mutant animals
were able to pass through the pupa stage but died within
3 days post-eclosion (Figure 3C).
We next determined the role of DMAD in demethylating 6mA
in vivo. We prepared genomic DNA from both wild-type and
DMAD1/2 mutant flies and measured the abundance of the
6mA base. As shown in Figure 3D, loss of DMAD led to a signif-
icant increase in the overall 6mA abundance in genomic DNA.
Of note, we found no difference in the abundance of 5mC and
5hmC between the wild-type and DMAD mutant flies (Figures
3E, S3A, and S3B), strongly arguing that the Drosophila DMAD
has no apparent in vivo role in regulating the conversion of
5mC to 5hmC. Moreover, we found that, while N3-methylcyto-
sine (3mC) and O6-methylguanine (m6G) were not detectable,
N1-methyladenine (1mA) (below 0.6 adduct per million dA) and
N3-methyladenosine (3mA) (about 2 adducts per million dA)
were present at low levels in both wild-type and DMAD mutant
flies, and no difference in relative abundance of 1mA and 3mA
bases was detected between wild-type and DMAD mutant flies
(Figure S3C; see Discussion). Additionally, we failed to detect
any apparent difference in levels of m6A abundance in RNA
between wild-type and DMAD mutant flies (Figure S3D). These
results together suggest that the DMAD specifically suppresses
the in vivo modification of 6mA, rather than 5mC and other
methylated DNA bases tested in this study, and m6A in RNA.
We then sought to determine the functional requirements
of the conserved domains (Figure S3F) in the DMAD protein
by generating specific domain-deletion alleles. To do so, we
designed two additional sgRNAs and attempted to use the
Cas9/sgRNA technique to locally produce truncated proteins
of the DMAD (Figure 3F). According to the experimental design,
we successfully obtained two new DMAD alleles, DMADdel-CXXC
and DMADdel-CD. These two alleles encode putative truncated
proteins, in which the CXXC domain and the catalytic domain
were deleted in DMAD, respectively (Figure 3F and Figure S3E).
Our genetic experiments showed that DMADdel-CXXC homo-
zygous mutant animals are viable and fertile and that the
DMADdel-CXXC allele is able to complement both DMAD1 and
DMAD2 alleles (Figure 3C). In addition, UHPLC-MRM-MS/MS
assays showed that the CXXC domain deletion did not cause
significant change in 6mA abundance in DNA between
DMADdel-CXXC homozygous and wild-type flies (Figure 3G).
Of note, in our western blot assays, we found that wild-type
flies also expressed a similar size protein as present in
DMADdel-CXXC homogote (Figure S3E). Taken together, these
results suggested that the CXXC domain is dispensable for theT-PCR.
y western blot assays.
ed in in vitro 6mA demethylation assays.
MAD or gfp were measured by qRT-PCR.
e used in in vitro 6mA DNA demethylation assays.
re calculated by Excel. See also Figure S2.
Cell 161, 893–906, May 7, 2015 ª2015 Elsevier Inc. 897
AC
F
B
D
E
G
H
Figure 3. DMAD Is Required for Drosophila
Development
(A) Schematic representation of DMAD mutant
allele generation using the CRISPR/Cas system.
The primer sequences of sgRNAs and information
for DMAD1 and DMAD2 are indicated.
(B) Western blot experiments showed that the
DMAD protein was completely abolished in the
DMAD1 and DMAD2 allelic backgrounds.
(C) Survival rates of wild-type, different DMAD
mutant, or overexpression flies at different devel-
opmental stages as indicated were measured.
(D and E) Abundance of 6mA (D) and 5mC (E) in
DNA from wild-type and DMAD1/2mutant flies was
measured by mass spectrometry.
(F) Schematic representation for the generation of
mutant alleles of DMAD using the CRISPR/Cas
system. The primer sequences of sgRNAs and
information for DMADdel-CXXC and DMADdel-CD are
provided.
(G and H) Abundance of 6mA in DNA from wild-
type, DMADdel-CXXC (G) and DMAD2/del-CD (H)
mutant flies was measured by mass spectrometry.
The experiments were carried out by triplicates,
and the standard deviations were calculated by
Excel. See also Figure S3.role of DMAD in development and in suppressing 6mAmodifica-
tion. By contrast, the DMADdel-CD completely failed to comple-
ment either theDMAD1 orDMAD2 allele. The trans-heterozygous
mutant DMADdel-CD/DMAD2 and DMADdel-CD/DMAD1 displayed
strong developmental defects (Figure 3C). Interestingly, we
found that the levels of 6mA modification were also increased
in the trans-heterozygous mutant background that carried
DMADdel-CD, compared to wild-type (Figure 3H). These results
together suggested that the catalytic domain is essential for
the role of DMAD in development and in suppressing 6mA
modification in vivo.
Additionally, we also examined the phenotypes in animals with
ectopic expression of the DMAD by generating the transgenic
flies, P{UASp-HA:DMAD}, in which the HA-tagged full-length
DMAD was placed under the control of the UASp promoter. As
shown in Figure 3C, overexpression of DMAD by the ubiquitous898 Cell 161, 893–906, May 7, 2015 ª2015 Elsevier Inc.driver, tub-gal4, at 29C caused lethality
at the late embryonic stage, since
embryos (n = 735) expressing DMAD
completely failed to develop to the larva
stage. However, relative low levels of
DMAD expression by the Gal4/Gal80ts
system (data not shown) permitted
28% (n = 810) of the DMAD expression
embryos to develop to the larva
stage. Interestingly, when we induced
the expression of the DMAD at the 10 hr
embryonic stage by taking advantage
of the temperature-dependent activity of
Gal80ts (see Extended Experimental
Procedures), we found that 49% of
DMAD-expressing embryos (n = 530)could develop to the larva stage. Thus, our findings suggested
that the DMAD expression must be under tight control during
embryonic development.
DMAD Promotes Differentiation of Early Germ Cells
in Drosophila
We next explored the potential roles of the DMAD in tissue
homeostasis. The Drosophila ovary offers an excellent model
system to study a number of important biological processes,
such as germline stem cell (GSC) regulation, oocyte determina-
tion, and epigenetic control (Lin, 2002; Ohlstein et al., 2004;
Spradling et al., 2001). A wild-type female contains a pair of
ovaries, each of which is composed of 16–20 ovarioles that
consist of an anterior functional unit (called ‘‘germarium’’) and
a linear string of differentiated egg chambers (Figures S4A and
S4B). In the tip of germarium, GSCs divide asymmetrically to
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Figure 4. DMAD and 6mA Patterns in the
Drosophila Ovary
(A and B) Ovaries from wild-type flies were stained
with anti-6mA antibody. (A) shows that 6mA signal
is highly expressed in the germarium region
and becomes gradually reduced and ultimately
disappears in germ cells of late egg chambers.
(B) indicates that 6mA marks both germ cells and
somatic cells. Scale bar, 10 mm.
(C–C0 0) Ovaries from wild-type flies were stained
with anti-DMAD and anti-Vasa antibodies. Weak
signal of anti-DMAD was indicated in the nucleus
of egg chamber nurse cells. Scale bar, 10 mm.
(D and D0) Ovaries from P{nosP-gal4:vp16}/P
{UASp-HA:DMAD}flies were stained with anti-
DMAD and anti-HA antibodies. Overlapping signal
of DMAD and HA was detected in germ cell nuclei
in germaria. Scale bar, 10 mm.
(E) Western blot assays show the levels of DMAD
protein expression during different stages of
embryonic development and in ovary.
(F and G) UHPLC-MRM-MS/MS chromatograms
(F) and quantification (G) showing 6mA abundance
in genomic DNA from wild-type and DMAD1/2
mutant ovaries.
The experiments were carried out by triplicates,
and the standard deviations were calculated by
Excel. See also Figure S4.produce two daughters. The anterior daughter cell retains con-
tact with the cap cells as a new stem cell, whereas the posterior
differentiating daughter cell becomes a cystoblast (CB) (Figures
S4C and S4D). The CB further divides four times with incomplete
cytokinesis, resulting in a cyst that sustains oogenesis (Fig-
ure S4D). To address whether DMAD has a role in germline,
we performed immunostaining experiments to investigate the
patterns of 6mA in the ovary. As shown in Figures 4A and 4B,
a striking 6mA staining signal was detected in the nucleus of
germarium cells, including germ cells and somatic cells (Fig-
ure 4B). In contrast, the 6mA signal was gradually reduced
with development and ultimately disappeared in germ cells of
mature differentiated egg chambers (Figure 4A), suggesting
that 6mA modification occurs in the germ cell in a developmen-
tally regulated fashion. We then determined DMAD expressionCell 161, 893in the germarium using the anti-DMAD
antibody. As shown in Figures 4C-4C0 0,
we detected no nuclear staining of the
DMAD in germarium germ cells, but a
faint signal was present in the nucleus in
egg chambers. To test whether the faint
signal from the anti-DMAD antibody was
specific, we performed further immuno-
staining in the germarium for ectopic
expression of the HA-tagged DMAD. As
shown in Figures 4D–4D0 and S4E-S4E0 0,
overlapping staining signals of HA with
DMAD in the nucleus of germ cells in
both germaria and egg chambers were
readily detected. These findings togethersuggest that DMAD expression occurs at a low level in the
ovary. In support of this, our western blot assays showed
that the DMAD protein expression was maintained at low
levels in the ovary as compared with in the embryo (Figure 4E).
We then tested whether DMAD has a role in regulating 6mA
modification in ovaries and found that loss of DMAD resulted
in an 10-fold increase in levels of 6mA in ovaries (Figures 4F
and 4G).
To test whether DMAD-mediated 6mA modification has a
role in regulating early germ cell development, we examined
the germ cell behavior in DMAD mutant ovaries by performing
immunostaining assays using anti-Vasa and anti-Hts antibodies,
which were used to visualize germ cells and fusomes, respec-
tively. As shown in Figures 5A–5E, a newly enclosed (1-day-
old) wild-type germarium normally contained 3–4 GSCs/CBs,–906, May 7, 2015 ª2015 Elsevier Inc. 899
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Figure 5. DMAD Promotes Early Germ Cell
Differentiation
(A–D) Ovaries from wild-type (A) and different
DMAD mutant flies as indicated were stained with
anti-Hts (Red) and anti-Vasa (Green) antibodies.
Scale bar, 10 mm.
(E) Quantification assay showing percentage of
type of germaria in wild-type and different DMAD
mutant ovaries corresponding to (A–D). The types
of germaria were classified according to the
number of spectrosome (Sp)-containing germ cells
in each germarium.
(F–I) Ovaries from wild-type and P{nosP-gal4:
vp16}/P{UASp-HA:DMAD} transgenic flies were
stained with anti-Hts (Red) and anti-Vasa (Green)
antibodies. Scale bar, 10 mm.
(J) Quantification assay showing percentage of
type of germaria in wild-type and P{nosP-gal4:
vp16}/P{UASp-HA:DMAD} ovaries corresponding
to (F–I).
See also Figure S5.whereas the 1-day-old DMAD mutant had an average of >8
spectrosome-containing germ cells (GSC-like cells) (Figures
5C and 5D), suggesting that DMAD plays a role in promoting
early germ cell differentiation. We next overexpressed DMAD
to examine the phenotype in germ cells by generating flies
carrying a transgene combination, P{UASp-HA:DMAD} and
P{nosP-gal4:vp16}, in which nosP-gal4:vp16 is a germ-cell-spe-
cific driver. As shown in Figures 5F–5J, S5A, and S5B, overex-
pression of DMAD led to a significant loss of germ cells, including
GSCs, supporting that DMAD plays a role in promoting GSC
differentiation.
DMAD Directly Catalyzes Demethylation of 6mA
To elucidate the biochemical properties of DMAD, we asked
whether DMAD directly catalyzes 6mA demethylation by
performing in vitro demethylation activity assays using the
ovarian nuclear extracts from wild-type and DMAD mutants.
As shown in Figure 6B, while wild-type ovarian nuclear extract
has considerable enzymatic activity for 6mA demethylation,
DMAD mutant nuclear extracts almost completely failed to900 Cell 161, 893–906, May 7, 2015 ª2015 Elsevier Inc.support the in vitro 6mA demethylation
reaction. In contrast, nuclear extracts
from DMAD mutant ovaries with addition
of the purified DMAD-CD protein, but
not DMAD-CDmut protein, resulted in
striking enzymatic activity for 6mA de-
methylation (Figures 6A and 6B). As
shown in Figure 6B, 46% of 6mA ba-
ses in the substrates were demethy-
lated, compared with only 20% having
demethylated 6mA in the control reac-
tion with the addition of AlkB or with nu-
clear extracts from wild-type ovaries.
Thus, our findings support that DMAD
is essential for 6mA demethylation in
Drosophila.We next tested whether DMAD has a similar role in other tis-
sues. The fly brain represents another interesting and comple-
mentary model to study the DMAD-mediated 6mA modification
due to two reasons. First, DMAD is expressed at a much higher
level in the fly brains than in ovaries (Figures 6C and 6D). Second,
levels of 6mA are also relatively low in the brain when compared
with very early-stage embryos (Figures 1C and 1E). We
measured abundance of 6mA in brain genome from wild-type
andDMADmutant brain tissue, respectively. Strikingly, we found
that loss of DMAD resulted in up to a 100-fold increase in 6mA
levels in brain (Figures 6E and 6F). Additionally, similar to ovary,
nuclear extracts from DMAD mutant brain with addition of
the purified DMAD-CD protein exhibited a considerable 6mA
demethylation activity (Figure S6A). Collectively, our findings
reveal that DMAD plays a critical role in the regulation of 6mA
demethylation in Drosophila.
Up to 100-fold increases of 6mA abundance in DMAD
mutant tissues raised a possibility that potential 6mA methyl-
ases catalyze 6mA methylation in fly DNA. To explore this
issue, we employed nuclear extracts from wild-type and
AC
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B Figure 6. DMAD Directly Catalyzes Deme-
thylation of 6mA
(A) Schematic diagram of the DMAD catalytic
domain (DMAD-CD) fragment (aa. 1657–2918) and
its mutant (DMAD-CDmut), in which two residues,
H1948 and D1950, were mutated to Y and A,
respectively. These two Fe(II)-binding sites are
located in the highly conserved ‘‘H-R/K/Q-D’’
motif, which has been shown to be important for
the catalytic activity in the family of AlkB-like Fe(II)/
a-ketoglutarate-dependent dioxygenases.
(B) The in vitro 6mA demethylation assays were
performed to test enzymatic activity in wild-type
ovary nuclear extracts, DMAD mutant ovary nu-
clear extracts without or with addition of the
DMAD-CD, or DMAD-CDmut protein as indicated.
(C and D) Levels of DMAD mRNA (C) and protein
expression (D) in ovary and brain were measured
by qRT-PCR and western blot assays, respec-
tively.
(E and F) UHPLC-MRM-MS/MS chromatograms
(E) and quantification (F) showing 6mA abundance
in genomic DNA from wild-type and DMAD1/2
mutant brains.
(G) Comparison for the enzymatic activity of DMAD
with its CD mutant form, AlkB, in the in vitro 6mA
demethylation assays.
(H) An in vitro enzymatic assay showing that the
DMAD protein directly catalyzes the 6mA deme-
thylation in a concentration-dependent manner.
The experiments were carried out by triplicates,
and the standard deviations were calculated by
Excel. See also Figure S6.DMAD mutant flies to perform in vitro 6mA methylation
assays. As shown in Figures S6B and S6C, wild-type nuclear
extracts showed a weak enzymatic activity for 6mA methyl-
ation, and DMAD mutant nuclear extracts exhibited relatively
high 6mA methylation activities. These findings suggest that
potential 6mA methylases and DMAD constitute an antago-
nistic loop to control 6mA base modification. Nevertheless,
our findings suggest that demethylation activity of DMAD
plays a predominant role in maintaining low levels of 6mA in
genome. To determine whether DMAD directly participates in
6mA demethylation, we performed in vitro DNA demethylation
assays. As shown in Figures 6G, 6H, and S6D, the purified
catalytic domain of DMAD (DMAD-CD), but not its dead
form of DMAD (DMAD-CDmut), is sufficient to promote 6mA
demethylation, suggesting that DMAD is the Drosophila 6mA
demethylase.Cell 161, 893DMAD-Mediated 6mA
Demethylation Is Correlated with
Transposon Expression
We next sought to test whether DMAD
influences 6mA modification of the
Drosophila genome. We collected
genomic DNA from 1-day-old wild-type
and DMAD mutant ovaries and per-
formed DNA immunoprecipitation (DNA-
IP) experiments using anti-6mA antibodyand then generated DNA libraries, which were subjected to
a high-throughput sequencing analysis. In this assay, the
IgG-immunoprecipitated DNA from an equivalent amount of
wild-type ovaries was used as the control, and 4.2–5.5 million
reads were obtained through high-throughput sequencing. We
then used MACS software (2.0 version, Zhang et al., 2008) to
identify the 6mA-enriched regions. In sum, we identified 161
and 491 peaks from wild-type and DMAD mutant samples,
respectively (Figure 7A). 88% of peaks identified in wild-type
are also identified in DMAD mutant sample, while 73% of
peaks in DMAD mutant sample were unique (Figure 7A). As
shown in Figures 7B and 7C, signal of 6mA was stronger in
DMAD mutant sample than wild-type sample with respect to
both common peaks and DMAD mutant unique peaks,
providing further evidence that 6mA demethylation is regulated
by DMAD.–906, May 7, 2015 ª2015 Elsevier Inc. 901
Figure 7. DMAD Controls 6mA Modification on Genome and Transposon Silencing
(A) 6mA enrichment peaks identified from wild-type and DMADmutant ovary samples. A significant portion of peaks are shared by wild-type and DMADmutant
ovary samples.
(legend continued on next page)
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Of note, our immunostaining assays revealed an evident
expansion of g-H2Av expression domain in late meiosis in
DMAD mutant germaria, compared with the wild-type control
(Figures S5C–S5D0). This phenomenon is also present in ago3
mutant germaria (Huang et al., 2014). We thus reasoned that
DMAD might be involved in transposon silencing by regulating
6mAmodification. Indeed, we found that 24% and 41%of peaks
fromwild-type andDMADmutants are located in the transposon
regions, respectively (Figure 7D), indicating that the transposon
sequence is the important 6mA-modified target by DMAD in
the genome. Additionally, we found that the 6mA signal was
much more enriched in the gene body of transposons when
compared with the upstream and downstream regions (Fig-
ure 7E). To link the 6mA modification with transposon expres-
sion, we employed wild-type and DMAD mutant samples to
perform RNA-seq analysis. Global expression profiling analysis
revealed that transposons with 6mA peaks express significantly
higher in DMAD mutant ovary than do those in wild-type
(Figure 7F).
We next performed qRT-PCR assays and measured levels of
transposon transcripts in wild-type and DMAD mutant ovaries,
respectively. As shown in Figure 7G, loss of DMAD led to an
increase in levels of most of the transposon transcripts that
we chose to evaluate. Particularly, Idefix, Het-A, Tart, and Copia
were significantly increased in the DMAD mutant, compared
with the control. Importantly, the 6mA DNA immunoprecipita-
tion followed by qPCR assays further confirmed that more
6mA modification occurs on the transposon regions in DMAD
mutant ovaries than in wild-type ovaries (Figures 7H, 7I, and
S7A–S7D). Taken together, our findings suggest that DMAD-
mediated 6mA demethylation is correlated with transposon
expression.
DISCUSSION
In this study, we find that 6mA is present in the Drosophila
DNA at a relatively high level at the very earliest embryonic
stages but at low levels at the late embryonic stages. Moreover,
we show that the dynamic change of 6mA modification
during embryonic development may involve an active demethy-
lation event, a process that is primarily regulated by the
Drosophila DMAD protein. Importantly, DMAD is essential for
Drosophila development and tissue homeostasis, perhaps
partially by suppressing adenine methylation and transposon
expression in ovary. Thus, our study suggests a potential role(B and C) The average 6mA signal strength of all common peaks (B) andDMADmu
than in wild-type ovary sample.
(D) Percentage of 6mA enrichment peaks located in transposon regions. 6mA pe
(E) The average 6mA signal strength on all 6mA peak-related transposons. The 6
(F) Accumulative distribution of expression levels of 6mA peak-related transpo
Wilcoxon rank sum test.
(G) qRT-PCR experiments were performed to measure the transposon expressio
(H) The 6mA-enriched regions are found in the Het-A transposon region in the ind
when compared with that of wild-type samples.
(I) qRCR experiments were performed to confirm the 6mA-enriched regions indic
In this assay, the corresponding regions IPed by IgG were used for normalization
were calculated by Excel. See also Figure S7.of the DMAD-6mA regulatory axis in controlling development in
higher eukaryotes.
Adenine Methylation in Drosophila
To date, studies examining 6mA as a biologically relevant, meth-
ylated DNA base have mainly been limited to bacteria, although
it is well known that 6mA is also present in the genomic DNA
of several unicellular eukaryotes (Wion and Casadesu´s, 2006).
Previous studies have reported that, while 5mC is enriched in
genomes of many higher eukaryotes, particularly mammals, a
signal for 6mA has not been detected (Ratel et al., 2006).
Because the important function of 5mC modification in mam-
mals has attracted much interest in the field of the epigenetic
control, the issue of whether adenine methylation occurs in gen-
eral and its related roles in higher eukaryote DNA has remained
largely unresolved. The previous failure to detect 6mA in
higher-eukaryote DNA could be that its level is so low in eukary-
otes that it was undetectable with the technology used in
previous reports (Lawley et al., 1972; Vanyushin et al., 1970).
However, adenine methylation might occur in a tissue-specific
or in a developmentally regulated manner in higher-eukaryote
cells (Raddatz et al., 2013), and low levels of 6mA could be
controlled by a tight negative regulatory mechanism mediated
by 6mA demethylases. Thus, searching for specific 6mA deme-
thylases is important for understanding the potential role of
adenine methylation in higher-eukaryote cells. In this study, we
show that the Drosophila DMAD directly catalyzes 6mA deme-
thylation in our biochemical assays, suggesting that it is likely
an 6mA demethylase. Moreover, our functional assays show
that loss of DMAD leads to strong developmental defects and
significantly increases the abundance of 6mA modification in
DNA. These findings bring an insight into understanding the
potential function of 6mA modification in development and
tissue homeostasis in higher eukaryotes. In this study, we find
that DMAD-mediated 6mA demethylation is correlated with
transposon suppression in ovary, indicating that 6mA modifica-
tion as an epigenetic mark likely regulates gene expression.
However, the possibility of other DMAD-mediated processes
contributing to normal development cannot be completely ruled
out and warrants further investigation.
The discovery that loss of DMAD causes a dramatic increase
of 6mA abundance in adult tissues opens an interesting possibil-
ity of the existence of potential 6mA methylases in flies for
DNA 6mA methylation. Our in vitro enzymatic assays revealed
that Drosophila nuclear extracts possess both methylation andtant unique peaks (C). 6mA signal was stronger inDMAD ovary mutant sample
aks were significantly located in transposon regions.
mA signal was enriched in transposon body.
sons in wild-type and DMAD mutant ovary samples. The p value represent
n levels in wild-type control and DMAD mutant ovary.
icated chromosome, in which DMADmutant samples show higher enrichment
ated in (H) when DMADmutant samples were compared with that of wild-type.
. The experiments were carried out by triplicates, and the standard deviations
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demethylation enzymatic activities for 6mA base modification.
Thus, it is likely that the potential 6mA methylase(s) and DMAD
act antagonistically to maintain the proper modification of
6mA in flies. It would be interesting to identify specific 6mA
methylases in the future.
Another question is whether DMAD is involved in the DNA
damage process and repair DNA methylation lesions. In this
study, we have measured the levels of 1mA, 3mC, 3mA, and
m6G because 1mA and 3mC are predominant forms of base
damage in single-stranded DNA, and 3mA and m6G are
products in double-stranded DNA damage (Lindahl et al.,
1988; Trewick et al., 2002). Our results revealed that loss of
DMAD did not cause apparent increase in levels of these bases.
Additionally, methyl iodide treatment did not cause apparent
upregulation of 6mA levels but led to a dramatic increase in levels
of m6G and 3mC in fly genomic DNA (Figures S3G–S3I). Thus,
our findings strongly argue that 6mA comes from enzymatic
installation rather than as a byproduct of DNA damage.The Role of DMAD in 6mA Demethylation in Drosophila
The controversy over 6mA inmammalian DNA is similar to that of
5mC modification in Drosophila and has been discussed for a
long time (Raddatz et al., 2013). A recent work suggested that
the Drosophila genome lacks a defined 5mC pattern (Raddatz
et al., 2013). In this study, we find that no evidence supports
oxidation of 5mC in Drosophila. Although DMAD can catalyze
the 5mC oxidation in in vitro enzymatic reactions, the in vivo
studies revealed no difference in levels of 5mC and 5hmC de-
tected in DNA from the wild-type and DMAD mutant flies,
revealing that the DMAD has no role in catalyzing 5mC oxidation
in vivo.
A broadly accepted concept is that DNA base modification
through methylation plays evolutionarily conserved epigenetic
roles in a wide array of organisms from bacteria to animals,
although the underlying mechanisms might be different among
species (Wion and Casadesu´s, 2006). From an evolutionary
perspective, since its DNA is not methylated at cytosine,
Drosophila likely uses other types of methylated bases, such
as 6mA, to fulfill the function of 5mC in mammals. The discovery
that DMADpossesses enzymatic activity for 6mAdemethylation,
as well as the identification of its role in suppressing 6mA
modification in vivo, support that DMAD functions as an 6mA
demethylase in Drosophila.
All AlkB family members contain a core catalytic domain called
the double-stranded b-helix (DSBH) fold (Shen et al., 2014).
Our results suggest that the DSBH domain in DMAD is essential
for its function in regulating 6mA demethylation in flies. It would
be interesting to search for DSBH-domain-containing dioxyge-
nases responsible for 6mA demethylation in mammals in the
future. Members of Tet family proteins, without a doubt, are
attractive candidates.EXPERIMENTAL PROCEDURES
Drosophila Strains
Fly stocks used in this study were maintained under standard culture condi-
tions. The w1118 strain was used as the host for all P-element-mediated trans-
formations. Strains P{tubP-gal80ts}, P{tubP-gal4}, and P{nosP-gal4:vp16}904 Cell 161, 893–906, May 7, 2015 ª2015 Elsevier Inc.have been maintained in the Chen lab. P{UASp-HA:DMAD} was generated
in this study; DMAD1, DMAD2, DMADdel-CXXC, and DMADdel-CD were gener-
ated by the CRISPR/Cas system in this study. See the Extended Experimental
Procedures for a more detailed protocol for generation of DMAD null alleles
using CRISPR/Cas system.
Immunohistochemistry
Ovaries were prepared for immunohistochemistry as described previously
(Yang et al., 2007). See the Extended Experimental Procedures for a more
detailed protocol.
Gene Knockdown in Drosophila Embryos
The dsRNA fragments corresponding to DMAD and gfp mRNAs were synthe-
sized in a PCR reaction and then fused to the T7 RNA polymerase binding site
at both 50 and 30 ends, which were used to generate theDMAD and gfp dsRNA
in vitro by using the RiboMAX Large Scale RNA kit (Promega) following the
manufacturer’s instructions. The DMAD or gfp dsRNA (1 mg/ml) was injected
into w1118 embryos. The embryos were incubated at room temperature for
turnover of the target protein.
Purification of Nuclear Extracts and Genomic DNA
Nuclear extracts were extracted from embryos or adult tissues using Minute
Cytoplasmic and Nuclear Extraction Kit (Invent Biotech). Genomic DNA was
extracted with Wizard genomic DNA purification Kit (Promega) following the
manufacturer’s instructions.
Anti-DMAD Antibodies
The anti-DMAD antibody was generated by immunizing rabbit andmouse with
the recombinant protein GST-DMAD (amino acids 959–1108) produced in
E. coli.
Immunodepletion Experiments
For immunodepletion experiments, 10 ml of protein A/G beadsweremixedwith
200 ml of hypotonic buffer (plus 0.02% CHAPS, 0.1 mM PMSF). This solution
wasmixedwith 10 mg rabbit anti-DMAD antibody or rabbit IgG andwas rotated
for about 1 hr using a head-to-tail roller at 4C. Embryonic nuclear extracts
were obtained as described above and were subjected to immunoprecipita-
tion using protein A/G beads treated with antibodies at 4C for 2 hr. Subse-
quently, samples were centrifuged and supernatants were collected and
used for in vitro 6mA demethylation assays.
Quantitative Real-Time PCR Analysis
qRT-PCR experiments were performed as described previously (Huang et al.,
2014). See the Extended Experimental Procedures for a more detailed
protocol.
Dot Blot Assay
Different amounts of standard DNA either containing the base dA or 6mA and
fly genomic DNA were used for dot blot assay. See the Extended Experimental
Procedures for a more detailed protocol.
UHPLC-MRM-MS/MS Analysis
Genomic DNAwas enzymatically digested into single nucleosides by amixture
of DNaseI, calf intestinal phosphatase, and snake venom phosphodiesterase
I at 37C for 12 hr. After the enzymes were removed by ultrafiltration, the
digested DNA was subjected to UHPLC-MS/MS analysis (Yin et al., 2013).
HPLC fractionation of Drosophila 6mA and UHPLC-QTOF-MS/MS analysis
are shown in the Extended Experimental Procedures with a more detailed
protocol.
In Vitro 6mA Demethylation
Calf thymus (CT) dsDNA was methylated by Dam methyltransferase following
the manufacturer’s instructions. The detailed protocol for 6mA demethylation
can be seen in the Extended Experimental Procedures.
Statistical Analysis
Data are presented as the mean +SEM from at least three independent
experiments. Student’s t test was used for comparison of two independent
groups. For all tests, a p < 0.05 was considered statistically significant.ACCESSION NUMBERS
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